Cuspis Capital II Ltd. Stock

Equities

CCII.P

CA23169N1087

Investment Holding Companies

Market Closed - Toronto S.E. 11:00:00 2024-04-16 EDT 5-day change 1st Jan Change
0.06 CAD -.--% Intraday chart for Cuspis Capital II Ltd. -.--% -40.00%
Sales 2022 - Sales 2023 - Capitalization 2.25M 3.06M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 -
Net cash position 2022 1.68M 2.29M Net cash position 2023 1.64M 2.23M EV / Sales 2023 -
P/E ratio 2022
-38 x
P/E ratio 2023
-70.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 84.8%
More Fundamentals * Assessed data
Dynamic Chart
11197894 Canada Ltd. (IC Group) entered into a letter of intent to acquire Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction. CI
Cuspis Capital II Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Cuspis Capital II Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Cuspis Capital II Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Peninsula Capital Corp. cancelled the acquisition of Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction. CI
Cuspis Capital II Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Cuspis Capital II Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Cuspis Capital II Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Cuspis Capital II Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Peninsula Capital Corp. entered into a letter of intent to acquire Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction. CI
Cuspis Capital II Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Cytophage Technologies Inc. cancelled the acquisition of Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction. CI
Cuspis Capital II Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital II Ltd. (TSXV:CCII.P) in a reverse merger transaction. CI
Cuspis Capital II Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
More news
6 months+71.43%
Current year-40.00%
More quotes
Current year
0.00
Extreme 0
0.07
1 year
0.00
Extreme 0
0.35
3 years
0.00
Extreme 0
0.45
5 years
0.00
Extreme 0
0.45
10 years
0.00
Extreme 0
0.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 19-08-31
Director of Finance/CFO 61 19-08-31
Members of the board TitleAgeSince
Director of Finance/CFO 61 19-08-31
Director/Board Member 66 19-08-31
Director/Board Member 67 19-08-31
More insiders
Cuspis Capital II Ltd is a Canada-based capital pool company. The Company’s principal purpose is the identification, evaluation and acquisition of assets, properties or businesses or participation. The Company has no revenue.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. CCII.P Stock